Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Ltd | Sector: Pharmaceuticals | ISIN: INE03QK01018

₹ 488.35 (-0.76%) icon

30 Jan, 2023, 3:53:05 PM
Open
₹ 492.10
Prev. Close
₹ 492.10
Turnover(lac)
₹ 466.53
Day's High
₹ 493.00
Day's Low
₹ 485.00
52 Wk High
₹ 631.75
52 Wk Low
₹ 390.50
Book Value
₹ 67.32
Face Value
₹ 1.00
Mkt. Cap (Cr.)
₹ 12,431.68
P/E
22.42
EPS
21.78
Div. Yield
1.02

Stock View

info icon
Edit Image

BUY

Target | 25 Jan, 2023

574.4 (16.72%)

Suven Pharmaceuticals Limited is an India-based company that is primarily engaged in providing services to global life science and fine chemical, including custom synthesis, process research... Read More

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 1/30/2023 3:53:05 PM

    ₹ 488.35 -3.75 -0.76
  • Open
  • ₹ 492.1
  • Prev. Close
  • ₹ 492.1
  • Turnover(Lac.)
  • ₹ 467
  • Day's High
  • ₹ 493
  • Day's Low
  • ₹ 485
  • 52 Week's High
  • ₹ 631.75
  • 52 Week's Low
  • ₹ 390.5
  • Book Value
  • ₹ 67.32
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 12,431.68
  • P/E
  • 22.42
  • EPS
  • 21.78
  • Divi. Yield
  • 1.02

Corporate Actions

01 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Nov , 2022

12:00 AM

02 Sep , 2022

12:00 AM

Dividend

Dividend amount: 1
Announcement date: 02 Sep , 2022

View Details

02 Sep , 2022

12:00 AM

Dividend

Dividend amount: 5
Announcement date: 02 Sep , 2022

View Details

29 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

09 May , 2022

12:00 AM

AGM

Announcement date: 09 May , 2022

View Details

01 Aug , 2022

12:00 AM

01 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

09 May , 2022

12:00 AM

Dividend

Dividend amount: 1
Announcement date: 09 May , 2022

View Details

09 May , 2022

12:00 AM

Dividend

Dividend amount: 1
Announcement date: 09 May , 2022

View Details

02 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Apr , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

08 Feb , 2022

12:00 AM

Dividend

Dividend amount: 1
Announcement date: 08 Feb , 2022

View Details

08 Feb , 2022

12:00 AM

Dividend

Dividend amount: 2
Announcement date: 08 Feb , 2022

View Details

01 Feb , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2022

12:00 AM

09 May , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
30 January , 2023 | 07:36 PM

PROMOTER - TOTAL60.00%

Indian: 60.00%

Foreign: 0%

NON-PROMOTER - TOTAL 40.00%

Institutions: 19.47%

Non-Institutions: 20.53%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

Suven Pharmaceuticals Ltd News and Update

Article Image
  • 7 hours ago |
  • 2:47 PM

Use of more technology in construction, can reduce construction time.

Article Image
  • IIFL News Service |
  • 23 January, 2023 |
  • 2:37 PM
Image not found
  • IIFL News Service |
  • 23 January, 2023 |
  • 2:37 PM
Image not found
  • IIFL News Service |
  • 20 January, 2023 |
  • 2:33 PM
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Suven Pharmaceuticals Ltd

  • Venkateswarlu Jasti

  • Managing Director
  • Deepanwita Chattopadhyay

  • Independent Director
  • V Sambasiva Rao

  • Independent Director
  • Jerry Jeyasingh

  • Non-Exec & Non-Independent Dir
  • Hanumantha Rao Kokkonda

  • Company Secretary
  • D G Prasad

  • Independent Director
  • J V Ramudu

  • Chairman & Non Executive Dir.

Summary

Suven Pharmaceuticals Limited (SPL) is a bio-pharmaceutical company, incorporated on 6th November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. The Company is a CDMO that supports global life sciences industry and fine chemical majors in their NCE development endeavors. Its services include custom synthesis, process R&D, scale-up and contract manufacturing of intermediates, APIs and formulations. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.During the year 2019-20, Suven Life Sciences Ltd. (SLSL) has transferred the CRAMS business undertaking to the Company in accordance with the Scheme of Arrangement (Demerger) approved by the Honble NCLT, Hyderabad Bench now integrated with Contract Development and Manufacturing Operations (CDMO) business model of the Company. In terms of the sanctioned Scheme, the Company issued and allotted 1 (One) fully paid up equity share of face value of Re 1/- (Rupee One only) each of SPL for every 1 (One) fully paid up equity share of face value of Re 1/- (Rupee One only) each held by each shareholder in the Demerged... Read More


Reports by Suven Pharmaceuticals Ltd


Reports by Suven Pharmaceuticals Ltd